2-(5-amino-6-oxo-2-phenyl-1,6-dihydropyrimidin-1-yl)-N-[(1R,2R)-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1-hydroxy-3-methylbutan-2-yl]acetamideRefChem:141534Ono 68182-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamideCHEMBL258925-Amino-N-[1-[[5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl]-6-oxo-2-phenyl-1(6H)-pyrimidineacetamideONO-6818;ONO-PO-736;ONO6818;ONO 68185-Amino-N-[1-[[5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl]-6-oxo-2-phenyl-1(6H)-pyrimidineacetamide; ONO 6818; ONO-PO 736
Database identifiers
CAS
208848-19-5
PubChem CID
216294
DTXSID
DTXSID50943150
ChEMBL
CHEMBL25892
UNII
1CW4RL23VP
Nikkaji
J1.647.741I
Properties
Computed structural properties
XLogP
2.6
Topological polar surface area
144 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
8
Rotatable bonds
8
Heavy atoms
33
Formal charge
0
Complexity
825
Physicochemical properties
Melting point
151 · 151-153oC
Density
1.32 · 1.32±0.1 g/cm3(Predicted)
storage temp.
-20 °C · -20°C Freezer
solubility
DMSO (Slightly), Methanol (Slightly)
pka
12.43 · 12.43±0.46(Predicted)
form
Solid
color
Off-White to Pale Yellow
FDA UNII
1 CW4RL23VP · 1CW4RL23VP
Chemistry & industry
Pharmacology
Mechanism of Action · 1 item
ONO-6818 inhibits neutrophil elastase activity, reducing interleukin 8 production and the formation of the complement membrane attack complex. Consequently, neutrophil elastase levels are reduced during stimulated extracorporeal circulation.
Applications
UsesFreselestat is a highly potent nonpeptidic orally active inhibitor of human neutrophil elastase (HNE) and can be used as treatment for neutrophil-predominant inflammatory lung diseases.